User Profile
Select your user profile
Events

The 25th International AIDS Conference

AIDS Conference

The 25th International AIDS Conference

22 - 26 July 2024

Munich, Germany, and virtually

Roche at the International AIDS Conference 2024

The 25th International AIDS Conference, will take place in Munich, Germany, and virtually, from 22 to 26 July 2024. 

Our portfolio of innovative diagnostic solutions will help meet the first and the third 95. Roche is committed to raising awareness about the importance of diagnostics in combating preventable diseases, strengthening laboratories, and improving infrastructure through strategic partnerships.  Together, with the community, we aim to emphasize the critical need for reliable testing and equitable access to healthcare, inspiring action to end AIDS by 2030 with the goal of creating a healthier future for generations to come. 

Roche continues to focus on solutions to make testing available to everyone, regardless of location. To enable greater access to HIV-1 viral load testing, an innovative collection device was developed to allow for reliable plasma viral load testing, without the need for phlebotomy, centrifugation, or refrigerated sample transportation. Our molecular based test for diagnosis is used to reliably determine the HIV status of babies born to HIV positive mothers. The test also meets the US guidelines for monitoring patients on Pre Exposure Prophylaxis (PrEP).1

Satellite Symposium

22 July 2024, 11:30 CET 
Munich, Germany
Hall B0b/Channel 5
 

Managing and thriving in HIV care: Advancing innovative solutions towards elimination of comorbidities such as HPV, HCV and TB

 

Finding time to constantly monitor one's viral load can be a challenge, so why not couple this activity with the peace of mind of an HPV screening test. In addition,  integrating low cost testing in our diagnostics ecosystem may expand TB diagnostics to reach the “missing millions”. When the next pandemic comes, let us make sure the most vulnerable populations are accessing testing in a health system that prioritizes them. The platform of HIV programmes proved capable of doing much more during the COVID pandemic, the challenge of funding streams or competing priorities does not need to stop progress.

Herry Mapesi, Roche Diagnostics

Dr. Jared Mecha, University of Nairobi

Lara Vojnov, Global Health Impact Group

 

eccmid

Join us in Roche booth 105

22- 26 July, 2024
Munich, Germany, 
Roche booth 105

Roche's Global Access Program is celebrating 10 years
Discover how our collaborative efforts with global, regional, and local partners are revolutionizing healthcare systems by expanding access to diagnostics. Join us to explore scalable, sustainable solutions that empower patients, healthcare professionals, and laboratories alike. You can enjoy:

  • Virtual reality systems experience - Imagine your future lab with our virtual reality simulation where you can interact with our instruments. The experience of walking through a high-functioning new lab and experiencing it for the first time as an interactive, immersive environment can be a revelation. Explore the lab configuration that best fits your needs.
  • Speak with our Roche representatives to learn more about optimizing solutions for your needs. 
  • Attend in-booth sessions on important topics in this space - more to come.
eccmid

In Booth Talks

Reference:

  1. cobas HIV-1/HIV-2, Qualitative nucleic acid test for use on the cobas 5800/6800/8800 Systems US-IVD Method Sheet 09198695001-05EN